You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Colorcon
AstraZeneca
Mallinckrodt
Express Scripts

Last Updated: March 7, 2021

DrugPatentWatch Database Preview

Litigation Details for Novartis Pharmaceuticals Corporation v. Roxane Laboratories Inc. (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Roxane Laboratories Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Novartis Pharmaceuticals Corporation v. Roxane Laboratories Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-09-16 1 United States Letters Patent No. 6,239,124 (“the ‘124 patent”). The ‘124 patent was duly and legally …United States Letters Patent No. 5,665,772 (“the ‘772 patent”). The ‘772 patent was duly and legally …United States Letters Patent No. 6,004,973 (“the ‘973 patent”). The ‘973 patent was duly and legally …United States Letters Patent No. 6,455,518 (“the ‘518 patent”). The ‘518 patent was duly and legally …772, ‘973, ‘124, and ‘518 patents was an act of infringement of those patents. 32. External link to document
2014-09-16 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 6,004,973; 6,239,124; 6,455,518…16 September 2014 1:14-cv-01196 830 Patent None District Court, D. Delaware External link to document
2015-10-16 73 Infringement Chart Concerning United States Patent Nos. 6,239,124 and 6,455,518 and (2) Plaintiffs Objections and…16 September 2014 1:14-cv-01196 830 Patent None District Court, D. Delaware External link to document
2015-10-16 85 Infringement Chart Concerning United States Patent Nos. 6,239,124 and 6,455,518 and (2) Plaintiffs Objections and…16 September 2014 1:14-cv-01196 830 Patent None District Court, D. Delaware External link to document
2015-12-09 92 , FAASLD Concerning Infringement of U.S. Patent No. 6,455,518, and (5) Opening Expert Report of Mitchell… Concerning Infringement of U.S. Patent Nos. 6,239,124 and 6,455,518 filed by Novartis AG, Novartis Pharmaceuticals…Bartlett, Ph.D. on Roxanes Infringement of U.S. Patent No. 5,665,772 (Zortress), (2) Opening Expert Report…Professor Alexander M. Klibanov on Infringement of U.S. Patent No. 6,004,973 by Defendant Roxane Laboratories,…16 September 2014 1:14-cv-01196 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Harvard Business School
Colorcon
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.